How to Reconstitute Peptides

Reconstitution is the process of dissolving a lyophilised (freeze-dried) peptide powder into a liquid solvent to create a solution suitable for laboratory use. Research peptides are supplied in lyophilised form because this maximises stability and shelf life during storage and transport. Before use in any laboratory application, the powder must be reconstituted correctly to preserve the peptide's integrity and ensure accurate concentration calculations. The lyophilisation process removes water under vacuum at low temperature, leaving a porous cake or loose powder that dissolves rapidly when the correct solvent is reintroduced. This is preferable to air drying or spray drying because it avoids the thermal degradation that liquid-phase drying inflicts on thermolabile sequences.

The most important decision in reconstitution is solvent selection. Bacteriostatic water (BAC water) is the recommended solvent for most research peptides and is the standard across the industry. It contains 0.9% benzyl alcohol as a preservative, which prevents bacterial growth and allows the reconstituted solution to be stored at +4°C for up to 4 weeks without contamination risk. Sterile water for injection contains no preservative and should only be used when the reconstituted solution will be used immediately or in a single session. For any laboratory situation where the vial will be accessed multiple times over days or weeks, bacteriostatic water is the correct choice. Acetic acid solution (0.1-1%) is occasionally used for peptides that are poorly soluble in water at neutral pH. Some hydrophobic or highly charged sequences dissolve more readily in mildly acidic conditions. Always consult the specific peptide's handling documentation before selecting a solvent. DMSO (dimethyl sulfoxide) is used in some in-vitro protocols for peptides with very poor aqueous solubility. When DMSO is required, the peptide is typically dissolved first in a small volume of DMSO and then diluted into aqueous buffer. Final DMSO concentration should be kept below 1% for most cell-based assays to avoid solvent toxicity. UKPL peptides are designed for aqueous reconstitution and bacteriostatic water is sufficient for the full catalogue.

• Lyophilised peptide vial • Bacteriostatic water (BAC water), available from UK Peptide Lab • Sterile insulin syringe (1ml) • Alcohol swabs • Clean, dust-free work surface Bacteriostatic water contains 0.9% benzyl alcohol as a preservative and is the recommended solvent for most research peptides. It prevents bacterial growth and allows the reconstituted solution to be stored at +4°C for up to 4 weeks. Optional but recommended for frequent laboratory use: nitrile gloves, a laminar flow hood or clean bench, and pre-labelled storage vials if aliquoting.

1. Allow both the peptide vial and the bacteriostatic water to reach room temperature. Rapid temperature changes during reconstitution can cause localised concentration gradients and incomplete dissolution. 2. Wipe the rubber stopper of both vials thoroughly with an alcohol swab and allow to air dry for 30 seconds. Do not blow on the stopper or touch the cleaned surface. 3. Draw the required volume of bacteriostatic water into a sterile syringe. For a standard 5mg vial, 2ml is a common starting point (giving 2.5mg/ml). Ensure no air bubbles are trapped in the syringe barrel. 4. Insert the needle into the peptide vial at an angle and slowly inject the bacteriostatic water down the inner side of the glass vial wall. Do not inject directly onto the powder. Inject slowly over 10-15 seconds. Direct impact on the lyophilised cake causes foaming and mechanical shear, both of which denature the peptide at the air-liquid interface. 5. Gently swirl the vial in a slow circular motion. Never shake. Shaking introduces air bubbles and can break peptide bonds through cavitation and surface denaturation. Allow 1-2 minutes for full dissolution. If the powder does not fully dissolve, place the vial in the refrigerator for 15-30 minutes and swirl again. 6. Once reconstituted, store the vial at +4°C (standard refrigerator temperature). Label the vial with the peptide name, concentration (mg/ml), and reconstitution date. Use within 4 weeks. Use the UK Peptide Lab reconstitution calculator for instant concentration calculations.

Concentration (mg/ml) = total peptide mg ÷ volume of BAC water added in ml Example: 5mg peptide + 2ml BAC water = 2.5mg/ml concentration To calculate the volume to draw for a specific quantity: volume (ml) = required mass (mg) ÷ concentration (mg/ml) Insulin syringe conversion: a standard U-100 insulin syringe reads in "units" where 100 units = 1ml. So 50 units = 0.5ml, 10 units = 0.1ml. This conversion is essential when working with dilute solutions where volumes are small. The reconstitution calculator linked below works this arithmetic for any combination of vial size and water volume, including the conversion to insulin syringe units.

Most UKPL peptides reconstitute straightforwardly in bacteriostatic water, but several compounds have handling characteristics worth noting: GHK-Cu: The reconstituted solution will have a characteristic blue colour. This is normal and expected, caused by the copper(II) complex. Store GHK-Cu solutions separately from other peptides, as free copper ions can catalyse oxidation of neighbouring compounds. BPC-157: Unusually stable among peptides, BPC-157 tolerates a wider pH range and dissolves rapidly. Standard bacteriostatic water is ideal. NAD+: Hygroscopic and photosensitive. Reconstitute promptly after opening the vial and protect the solution from light. NAD+ degrades faster than most peptides in solution, so prepare only what will be used within 1-2 weeks rather than the standard 4-week window. Glutathione: The reduced form (GSH) is sensitive to oxidation. Minimise air exposure during reconstitution and cap the vial immediately. Reconstituted glutathione is best used within 1-2 weeks. GLOW and KLOW stacks: These multi-peptide blends reconstitute in a single step. The GHK-Cu component produces the expected blue colour. Because three or four compounds share one vial, the total mass is higher (70-80mg), so a larger volume of bacteriostatic water (2-3ml) is appropriate to keep all components fully in solution. Melanotan I and II: Standard reconstitution. Protect from light exposure both during and after reconstitution, as melanocortin peptides are photosensitive. IGF-1 LR3: Some research protocols use mildly acidic reconstitution buffers for IGF analogues. Bacteriostatic water works for standard applications. If your protocol specifies 0.1M acetic acid, prepare this separately.

Standard peptide vials used by UKPL are 2ml or 3ml crimp-cap borosilicate glass. The physical capacity constrains the maximum volume of water you can add: • 2ml vial: maximum practical fill is approximately 1.5-1.8ml, accounting for the stopper and needle displacement. • 3ml vial: maximum practical fill is approximately 2.5-2.8ml. If a protocol requires a more dilute solution than the vial volume allows, reconstitute at the maximum concentration the vial permits, then transfer to a larger sterile container and dilute further. Always perform the initial reconstitution in the original vial, as the lyophilised cake adheres to the glass surface it was freeze-dried on. For larger-format products (Glutathione 1500mg, NAD+ 500mg, L-Carnitine 600mg), the vials are sized to accommodate the larger mass and appropriate reconstitution volumes are noted on the product page.

• Shaking instead of swirling: always swirl gently. Shaking creates foam and the air-liquid interface denatures peptides. • Using tap water or non-sterile water: always use bacteriostatic water. Tap water contains chlorine, minerals, and microorganisms that compromise the compound. • Injecting directly onto the powder: always inject down the glass wall. Direct impact causes splashing and foaming. • Not labelling the vial: record the peptide name, concentration, and reconstitution date. Unlabelled vials are a contamination and dosing error risk. • Repeatedly freezing and thawing a reconstituted vial: aliquot first if long-term storage is needed. Each freeze-thaw cycle forms ice crystals that mechanically damage the peptide chain. • Using a blunt or re-used needle: each vial entry should use a fresh sterile needle. Reuse introduces coring (rubber fragments in solution) and bacterial contamination. • Reconstituting too far in advance: peptides in solution degrade faster than in lyophilised form. Only reconstitute what will be used within the 4-week window.

Reconstituted peptides remain stable at +4°C for up to 4 weeks when prepared with bacteriostatic water. For longer term storage, draw the solution into multiple small syringes or vials (aliquots) and store at -20°C. This prevents repeated freeze-thaw cycles which degrade peptide quality over time. Never refreeze a vial that has already been thawed and partially used. Aliquoting protocol: 1. Immediately after reconstitution, calculate the number of aliquots needed. 2. Using a fresh sterile syringe for each, draw the required volume and transfer to pre-labelled sterile microcentrifuge tubes or vials. 3. Place aliquots directly into a -20°C freezer. 4. When needed, thaw a single aliquot at room temperature or in the refrigerator. Use the entire aliquot. Do not refreeze. Signs of degradation to watch for: cloudiness or turbidity (aggregation), visible particulates, colour changes (excluding GHK-Cu's normal blue), unusual odour (bacterial contamination), or a peptide that previously dissolved easily now resisting dissolution.

Maintaining sterile conditions throughout the reconstitution process is essential for research reproducibility. Contaminated solutions introduce confounding variables and can produce misleading results in any downstream assay. Key practices: • Work on a clean, recently disinfected surface. A laminar flow hood is ideal but not always available. At minimum, wipe the work area with 70% isopropanol before beginning. • Swab every vial stopper with alcohol before every needle entry, including the bacteriostatic water vial. • Use a fresh sterile syringe and needle for each vial. Never reuse syringes between different compounds. • Minimise the time the vial stopper is exposed. Insert the needle, perform the transfer, and remove it. Do not leave needles inserted in stoppers. • Wear nitrile gloves when handling vials and syringes. • Dispose of sharps in an appropriate container. Never recap needles.